scholarly journals Docosahexaenoic acid disruptsin vitroamyloid β1-40fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model rats

2008 ◽  
Vol 107 (6) ◽  
pp. 1634-1646 ◽  
Author(s):  
Michio Hashimoto ◽  
Hossain Md Shahdat ◽  
Shinji Yamashita ◽  
Masanori Katakura ◽  
Yoko Tanabe ◽  
...  
Neuroscience ◽  
2011 ◽  
Vol 197 ◽  
pp. 358-368 ◽  
Author(s):  
T. Kurata ◽  
K. Miyazaki ◽  
M. Kozuki ◽  
N. Morimoto ◽  
Y. Ohta ◽  
...  

2002 ◽  
Vol 81 (5) ◽  
pp. 1084-1091 ◽  
Author(s):  
Michio Hashimoto ◽  
Shahdat Hossain ◽  
Toshio Shimada ◽  
Kozo Sugioka ◽  
Hiroshi Yamasaki ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Lishu Duan ◽  
Mufeng Hu ◽  
Joseph A. Tamm ◽  
Yelena Y. Grinberg ◽  
Fang Shen ◽  
...  

AbstractAlzheimer’s disease (AD) is a common neurodegenerative disease with poor prognosis. New options for drug discovery targets are needed. We developed an imaging based arrayed CRISPR method to interrogate the human genome for modulation of in vitro correlates of AD features, and used this to assess 1525 human genes related to tau aggregation, autophagy and mitochondria. This work revealed (I) a network of tau aggregation modulators including the NF-κB pathway and inflammatory signaling, (II) a correlation between mitochondrial morphology, respiratory function and transcriptomics, (III) machine learning predicted novel roles of genes and pathways in autophagic processes and (IV) individual gene function inferences and interactions among biological processes via multi-feature clustering. These studies provide a platform to interrogate underexplored aspects of AD biology and offer several specific hypotheses for future drug discovery efforts.


Sign in / Sign up

Export Citation Format

Share Document